Mei-Shih Announces Board Approval to Cancel Fund Lending to Subsidiary Lotus International Pte. Ltd.
Key facts
- Mei-Shih Announces Board Approval to Cancel Fund Lending to Subsidiary Lotus International Pte. Ltd.
- Mei-Shih Chemical Pharmaceutical Co., Ltd. has resolved at its board meeting to cancel a USD 20 million fund lending facility to its subsidiary, Lotus International Pte. Ltd., aligning with current operational realities.
- Source: PR Times
- Date: June 26, 2026
Direct answer
Mei-Shih Chemical Pharmaceutical Co., Ltd. has resolved at its board meeting to cancel a USD 20 million fund lending facility to its subsidiary, Lotus International Pte. Ltd., aligning with current operational realities.
- Citation
- Mei-Shih Announces Board Approval to Cancel Fund Lending to Subsidiary Lotus International Pte. Ltd. (June 26, 2026), PR Times
- Source
- PR Times
- Date
- June 26, 2026
Mei-Shih Chemical Pharmaceutical Co., Ltd. has resolved at its board meeting to cancel a USD 20 million fund lending facility to its subsidiary, Lotus International Pte. Ltd., aligning with current operational realities.
📋 Article Processing Timeline
- 📰 Published: June 26, 2026 at 09:00
- 🔍 Collected: June 27, 2026 at 17:00 (32h 0m after Published)
- 🤖 AI Analyzed: June 27, 2026 at 18:52 (1h 52m after Collected)
1. Factual Date: 115/06/26
2. Company Name: Mei-Shih Chemical Pharmaceutical Co., Ltd.
3. Relationship with Company (Please enter '本公司' or 'Subsidiary'):本公司 (Parent Company)
4. Cross-shareholding Ratio: 100%
5. Reason for Occurrence: In alignment with the company's actual operational status, the board has decided to cancel the USD 20 million fund lending facility to its subsidiary, Lotus International Pte. Ltd.
6. Countermeasures: Not applicable
7. Other Matters to be Disclosed (If the subject of the event or resolution is a publicly listed company or above, this significant information also qualifies under Article 7, Paragraph 9 of the Enforcement Rules of the Securities and Exchange Act as a matter having significant impact on shareholders' rights or securities prices): None
Keywords: Significant Information
2. Company Name: Mei-Shih Chemical Pharmaceutical Co., Ltd.
3. Relationship with Company (Please enter '本公司' or 'Subsidiary'):本公司 (Parent Company)
4. Cross-shareholding Ratio: 100%
5. Reason for Occurrence: In alignment with the company's actual operational status, the board has decided to cancel the USD 20 million fund lending facility to its subsidiary, Lotus International Pte. Ltd.
6. Countermeasures: Not applicable
7. Other Matters to be Disclosed (If the subject of the event or resolution is a publicly listed company or above, this significant information also qualifies under Article 7, Paragraph 9 of the Enforcement Rules of the Securities and Exchange Act as a matter having significant impact on shareholders' rights or securities prices): None
Keywords: Significant Information
FAQ
Who made the decision to cancel the fund lending?
The board of directors of Mei-Shih Chemical Pharmaceutical officially resolved the cancellation.
Where is Lotus International Pte. Ltd. located?
It is a Singapore-incorporated entity serving as the international hub for the Mei-Shih Group.
Will this affect future dividends?
Improved financial health may support stable dividend growth in the medium to long term.